CLosure of Trading window for quarter and half year ended 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences has informed BSE that its trading window for insiders will be closed from 1st October, 2025 until 48 hours after the upcoming Board Meeting. The window closure is in line with SEBI's Insider Trading Regulations and the company's internal code of conduct. The Board Meeting, which will consider the unaudited standalone and consolidated financial results for Q2 and the half year ending 30th September, 2025, will be announced separately. All designated persons and their immediate relatives are barred from trading in the company's shares during this period.
This is a routine compliance filing and does not directly affect shareholders. However, it signals that the company's Q2 and H1 FY26 financial results are due soon, which could be a near-term catalyst for stock movement once announced.